BlackRock
NBP

BlackRock’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

BlackRock’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
686,208
+58,712
+9% +$120K ﹤0.01% 4262
2026
Q1 		$1.54M Buy
627,496
+9,149
+1% +$30.6K ﹤0.01% 4202
2025
Q4 		$2.46M Buy
+618,347
New +$2.74M ﹤0.01% 4063
2024
Q4 		– Sell
-1,438
Closed -$1.78K – 5422
2024
Q3 		$1.78K Sell
1,438
-6,246
-81% -$7.82K ﹤0.01% 5112
2024
Q2 		$12.8K Sell
7,684
-239
-3% -$427 ﹤0.01% 5046
2024
Q1 		$14.7K Sell
7,923
-92,142
-92% -$170K ﹤0.01% 5056
2023
Q4 		$190K Sell
100,065
-623,215
-86% -$931K ﹤0.01% 4653
2023
Q3 		$955K Sell
723,280
-1,335,361
-65% -$2.93M ﹤0.01% 4259
2023
Q2 		$6.16M Buy
2,058,641
+111,990
+6% +$360K ﹤0.01% 3637
2023
Q1 		$6.74M Sell
1,946,651
-43,803
-2% -$212K ﹤0.01% 3509
2022
Q4 		$8.32M Sell
1,990,454
-281,217
-12% -$1.06M ﹤0.01% 3483
2022
Q3 		$9.11M Sell
2,271,671
-366,161
-14% -$2.78M ﹤0.01% 3474
2022
Q2 		$29.8M Sell
2,637,832
-765,439
-22% -$9.18M ﹤0.01% 2856
2022
Q1 		$55.3M Buy
3,403,271
+938,531
+38% +$24.1M ﹤0.01% 2530
2021
Q4 		$117M Buy
2,464,740
+572,142
+30% +$34.3M ﹤0.01% 2112
2021
Q3 		$137M Buy
1,892,598
+100,726
+6% +$7.28M ﹤0.01% 1998
2021
Q2 		$150M Buy
1,791,872
+1,631,988
+1,021% +$108M ﹤0.01% 1986
2021
Q1 		$7.75M Buy
159,884
+12,929
+9% +$701K ﹤0.01% 3720
2020
Q4 		$6.93M Buy
146,955
+144,871
+6,952% +$5.7M ﹤0.01% 3554
2020
Q3 		$98K Buy
+2,084
New +$68.7K ﹤0.01% 4516
2020
Q2 		– Sell
-509
Closed -$7K – 5062
2020
Q1 		$7K Buy
+509
New +$6.36K ﹤0.01% 4744

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock's NBP Position: Q2 2026 in Review

BlackRock increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 9.4% in Q2 2026, buying an estimated $120K and bringing the position to 686,208 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4262.

BlackRock first reported a position in NBP in Q1 2020 and has held it in 21 quarters since. The position peaked at $150M in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • BlackRock held 686,208 shares of NovaBridge Biosciences American Depositary Shares worth $1.34M as of Q2 2026.
  • BlackRock bought 58,712 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $120K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4262 holding.
  • BlackRock first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2020 and has held it in 21 quarters since.
  • BlackRock's NovaBridge Biosciences American Depositary Shares position peaked at $150M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.